Better Therapeutics to Host Call Detailing Promising Results from Pivotal Clinical Trial for Type 2 Diabetes Digital Therapeutics
![Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials | The BMJ Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials | The BMJ](https://www.bmj.com/content/bmj/343/bmj.d6898/F1.large.jpg)
Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials | The BMJ
![Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data - The Lancet Diabetes & Endocrinology Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data - The Lancet Diabetes & Endocrinology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cb1467c8-51ef-4a3a-85e8-3143959f4215/gr1_lrg.jpg)
Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data - The Lancet Diabetes & Endocrinology
![Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme | SpringerLink Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-020-05224-2/MediaObjects/125_2020_5224_Figa_HTML.png)
Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme | SpringerLink
![Insulin delivery with a needle-free insulin injector versus a conventional insulin pen in Chinese patients with type 2 diabetes mellitus: A 16-week, multicenter, randomized clinical trial (the FREE study) - eClinicalMedicine Insulin delivery with a needle-free insulin injector versus a conventional insulin pen in Chinese patients with type 2 diabetes mellitus: A 16-week, multicenter, randomized clinical trial (the FREE study) - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/a2471669-cb15-43e3-9c7a-1413a17d561f/gr1.jpg)
Insulin delivery with a needle-free insulin injector versus a conventional insulin pen in Chinese patients with type 2 diabetes mellitus: A 16-week, multicenter, randomized clinical trial (the FREE study) - eClinicalMedicine
![Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus – A pooled meta-analysis of randomized placebo-controlled clinical trials - International Journal of Cardiology Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus – A pooled meta-analysis of randomized placebo-controlled clinical trials - International Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1060049/7767032/gr1.jpg)
Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus – A pooled meta-analysis of randomized placebo-controlled clinical trials - International Journal of Cardiology
![Evidence-based and tailored medication in type 2 diabetes: a pathway learned from clinical trials | Cardiovascular Diabetology | Full Text Evidence-based and tailored medication in type 2 diabetes: a pathway learned from clinical trials | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-019-0834-0/MediaObjects/12933_2019_834_Fig1_HTML.png)
Evidence-based and tailored medication in type 2 diabetes: a pathway learned from clinical trials | Cardiovascular Diabetology | Full Text
![Metabolic changes induced by dapagliflozin, an SGLT2 inhibitor, in Japanese patients with type 2 diabetes treated by oral anti-diabetic agents: A randomized, clinical trial - Diabetes Research and Clinical Practice Metabolic changes induced by dapagliflozin, an SGLT2 inhibitor, in Japanese patients with type 2 diabetes treated by oral anti-diabetic agents: A randomized, clinical trial - Diabetes Research and Clinical Practice](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/941c732f-29b1-4d08-a1e7-89677dcdb56d/gr1.jpg)
Metabolic changes induced by dapagliflozin, an SGLT2 inhibitor, in Japanese patients with type 2 diabetes treated by oral anti-diabetic agents: A randomized, clinical trial - Diabetes Research and Clinical Practice
![Challenging Recruitment of Youth With Type 2 Diabetes Into Clinical Trials – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub. Challenging Recruitment of Youth With Type 2 Diabetes Into Clinical Trials – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.](https://cyberleninka.org/viewer_images/247611/f/1.png)
Challenging Recruitment of Youth With Type 2 Diabetes Into Clinical Trials – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
![Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes - American Journal of Cardiology Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes - American Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7bf8d601-3abf-4895-afb3-6cdcbf1fd3b5/gr1.jpg)